CTA
CVS icon

Colonial Trust Advisors’s CVS Health CVS Stock Holding History

Colonial Trust Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$172K Buy
2,400
+1,912
+392% +$147K 0.01% 211
2025
Q4 		$38.7K Sell
488
-85
-15% -$6.7K ﹤0.01% 375
2025
Q3 		$43.2K Buy
573
+324
+130% +$22.2K ﹤0.01% 360
2025
Q2 		$17.2K Sell
249
-51
-17% -$3.34K ﹤0.01% 459
2025
Q1 		$20.3K Sell
300
-28
-9% -$1.68K ﹤0.01% 430
2024
Q4 		$14.7K Sell
328
-511
-61% -$28.7K ﹤0.01% 443
2024
Q3 		$52.7K Sell
839
-33
-4% -$1.93K ﹤0.01% 329
2024
Q2 		$51.5K Sell
872
-477
-35% -$29.8K ﹤0.01% 319
2024
Q1 		$108K Sell
1,349
-95
-7% -$7.26K 0.01% 238
2023
Q4 		$114K Sell
1,444
-140
-9% -$9.96K 0.01% 223
2023
Q3 		$111K Sell
1,584
-29
-2% -$2.06K 0.01% 234
2023
Q2 		$112K Sell
1,613
-97
-6% -$6.9K 0.01% 238
2023
Q1 		$127K Sell
1,710
-255
-13% -$21.4K 0.01% 226
2022
Q4 		$183K Hold
1,965
– – 0.02% 203
2022
Q3 		$187K Buy
+1,965
New +$195K 0.03% 194
2018
Q1 		– Sell
-3,520
Closed -$255K – 152
2017
Q4 		$255K Buy
+3,520
New +$256K 0.04% 150

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Colonial Trust Advisors's CVS Position: Q1 2026 in Review

Colonial Trust Advisors increased its CVS Health (CVS) stake by 392% in Q1 2026, buying an estimated $147K and bringing the position to 2,400 shares worth $172K. The position accounts for 0.01% of the portfolio, ranked #211.

Colonial Trust Advisors first reported a position in CVS in Q4 2017 and has held it in 16 quarters since. The position peaked at $255K in Q4 2017. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Colonial Trust Advisors held 2,400 shares of CVS Health worth $172K as of Q1 2026.
  • Colonial Trust Advisors bought 1,912 CVS Health shares in Q1 2026, an estimated $147K.
  • CVS Health made up 0.01% of Colonial Trust Advisors's portfolio in Q1 2026, its #211 holding.
  • Colonial Trust Advisors first reported a position in CVS Health in Q4 2017 and has held it in 16 quarters since.
  • Colonial Trust Advisors's CVS Health position peaked at $255K in Q4 2017.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Colonial Trust Advisors's 13F filing for Q1 2026, filed 12 May 2026.